Have Your Impulses Been Under Attack From Using Abilify? It’s Time to Fight Back!
Abilify, a world-leading antipsychotic medication prescribed to individuals with severe depression, bipolar depression, and schizophrenia, has been linked to life-altering compulsive disorders that patients were never warned could occur.
Damaging Side Effects Without Warning
Abilify was approved by the FDA for patient use in 2002. Beginning around 2009, thousands of users began reporting experiences of significant impulse-control problems that were recorded in medical studies including:
- Compulsive gambling.
- Sexual urges
- Eating and binge eating
These side-effects were not acknowledgement by the FDA in writing until August 2016, when a warning label began accompanying the medication.
Before the label was added, millions of Abilify users were blindly taking the medication to treat their conditions, unknowingly succumbing to urges that may have been directly caused by ingesting the prescribed dose.
This led to further devastating side effects, including:
- Economic losses from gambling
- Emotional distress from compulsive actions
- Loss of spousal and family trust
- Treatment costs for addictions to food, sex, gambling, and compulsive activities
With over 1.5 million people prescribed Abilify, the damaging reach is being verified through legal paths, including claims filed in multiple states denouncing the lack of warnings as the leading reason for their sales and use by consumers.
How Can This Happen?
Otsuka America Pharmaceutical, in conjunction with Bristol-Myers Squibb, began marketing the drug without the warning, even though they should have had a reasonable knowledge of these side effects from their studies. Pharmaceutical companies move fast and want results that bolster sales. The FDA approves drugs with the information provided, even though the medical oversights can be harmful to the public. Not unlike most dangerous drugs, something terrible must happen before the patients are warned after the fact. By then, the financial, emotional, and psychological damage is done.
What Is Bertoldo, Baker, Carter, Smith & Cullen Doing About It?
Prescription medications are designed to help individuals combat afflictions they cannot overcome on their own, not to create new hazards in their lives.
At Bertoldo, Baker, Carter, Smith & Cullen, we invite individuals who suffered from compulsive disorders after taking Abilify to call our Las Vegas, NV office today at (702) 505-8115 to join the nation’s master complaint that was formed in September 2017. We provide free confidential consultations where we can discuss your case without delay. Call us now to join the fight for justice.